Log in

Integra Lifesciences Price Target & Analyst Ratings (NASDAQ:IART)

$60.88
0.00 (0.00 %)
(As of 12/11/2019 02:50 AM ET)
Today's Range
$60.46
Now: $60.88
$61.49
50-Day Range
$55.73
MA: $59.32
$62.27
52-Week Range
$42.14
Now: $60.88
$65.09
Volume203,209 shs
Average Volume437,567 shs
Market Capitalization$5.23 billion
P/E Ratio25.16
Dividend YieldN/A
Beta1.11

Analyst Ratings

Integra Lifesciences (NASDAQ:IART) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
9 Wall Street analysts have issued ratings and price targets for Integra Lifesciences in the last 12 months. Their average twelve-month price target is $61.89, suggesting that the stock has a possible upside of 1.66%. The high price target for IART is $75.00 and the low price target for IART is $50.00. There are currently 4 hold ratings and 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyHoldHold
Consensus Rating Score: 2.562.502.452.36
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
5 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $61.89$61.50$62.45$58.90
Price Target Upside: 1.66% upside7.56% upside1.29% downside14.48% upside

Integra Lifesciences (NASDAQ:IART) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Integra Lifesciences (NASDAQ:IART) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/25/2019OppenheimerSet Price TargetBuy$68.00N/A
10/25/2019Royal Bank of CanadaSet Price TargetHold$62.00N/A
10/25/2019Wells Fargo & CoSet Price TargetHold$62.00N/A
7/25/2019JMP SecuritiesBoost Price Target$75.00Medium
7/24/2019BTIG ResearchSet Price TargetBuy$70.00Low
2/22/2019Morgan StanleySet Price TargetHold$57.00Medium
2/21/2019Cantor FitzgeraldReiterated RatingHold$50.00High
1/3/2019SunTrust BanksInitiated CoverageBuy ➝ Buy$56.00High
12/17/2018Credit Suisse GroupInitiated CoverageOutperform$57.00Medium
11/27/2018UBS GroupInitiated CoverageNeutral ➝ Neutral$58.00High
11/2/2018CitigroupLower Price TargetNeutral ➝ Neutral$66.00 ➝ $60.00Low
8/7/2018Bank of AmericaDowngradeNeutral ➝ UnderperformMedium
5/22/2018JPMorgan Chase & Co.Boost Price TargetNeutral ➝ Neutral$57.00 ➝ $65.00Low
3/1/2018Jefferies Financial GroupReiterated RatingBuy$63.00Low
1/9/2018BarclaysReiterated RatingHold$53.00Low
1/2/2018Raymond JamesReiterated RatingOutperform ➝ Market Perform$55.00Medium
(Data available from 12/11/2017 forward)
This page was last updated on 12/11/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel